The Latin America NGS market

1
Latin America NGS Market to be Worth 765.2
Million by 2032
2
Global Latin America NGS Market 2025-2032
Meticulous Researcha leading global market
research company, published a research report
titled, "Latin America NGS Market by Offering
(Kits Library Prep, QC, DNA Extraction, System)
Type (Genome, Exome, Targeted) Application
(Reproductive, Oncology, Infectious, Drug
Discovery) Technology (SBS, Nanopore, Nanoball,
SMRT Seq, DNB) - Forecast to 2032." According to
this latest publication from Meticulous
Research, the Latin America NGS market is
expected to reach 765.2 million by 2032, at a
CAGR of 13.9 from 2025 to 2032. The growth of
the Latin America NGS market can be attributed to
various factors, including the increasing
initiatives by governments and organizations for
genomic sequencing projects, advancements in
sequencing procedures, decreasing costs of genome
sequencing, a rise in cancer prevalence, and the
expanding application of NGS in cancer treatment
and research. However, the high costs of NGS
systems and consumables and the availability of
alternative technologies restrain the market's
growth. The rising adoption of bioinformatics
and genomic data management solutions, as well as
collaborations and partnerships to support
next-generation sequencing, are expected to
create market growth opportunities. However, the
lack of skilled professionals and ethical and
legal issues related to NGS-based diagnosis pose
a significant challenge to the market's
growth. Key Players The key players profiled in
the Latin America NGS market report are Thermo
Fisher Scientific Inc. (U.S.), Illumina, Inc.
(U.S.), Qiagen N.V. (Netherlands), F. Hoffmann-La
Roche Ltd (Switzerland), PerkinElmer, Inc.
(U.S.), Agilent Technologies, Inc. (U.S.),
Danaher Corporation (U.S.), Bio-Rad Laboratories,
Inc. (U.S.), Oxford Nanopore Technologies Plc.
(U.K.), and 10X Genomics, Inc. 2(U.S.). Latin
America NGS Market Future Outlook The Latin
America NGS market is segmented into Offering
(Consumables Sample Preparation Consumables DNA
Extraction and Amplification, Library Preparation
Target Enrichment, Quality Control, Other
Consumables, NGS Platforms/Instruments,
Software, Services), Sequencing Type (Targeted
Genome Sequencing, Whole Genome Sequencing, Whole
Exome Sequencing, Other Sequencing Types),
Technology (Sequencing by Synthesis, Ion
Semiconductor Sequencing, Single-molecule
Real-time Sequencing (SMRT), Nanopore Sequencing,
DNA Nanoball Sequencing), Applications (Clinical
Applications Reproductive Health, Oncology,
Infectious Diseases, Other Clinical
Applications, Research Applications Drug
Discovery, Agriculture Animal Research, Other
Research Applications), End User (Hospitals and
Diagnostic Laboratories, Pharmaceutical
Biotechnology Companies, Academic Institutes
Research Centers, Other End Users), and
Geography. Among the offerings, in 2025, the
consumables segment is expected to account for
the largest share of the Latin America NGS
market. The large market share of this segment is
attributed to recurring demand for consumables,
advancements in consumables, and the rising
adoption of NGS technology for clinical and
research purposes. NGS is used in clinical and
research studies to characterize disease-causing
genomes, sequence the potential pathogen, analyze
epigenetic markers, and identify specific genes
and their sequences. These applications of NGS
are instrumental in developing targeted
medicines, understanding food microbiology and
microbiota analysis in the beverage industry, and
other environmental studies.
Meticulous Research sales_at_meticulousresearch.co
m
3
Global Latin America NGS Market 2025-2032

• Among the sequencing types, in 2025, the targeted
  genome sequencing segment is expected to account
  for the largest share of the Latin America NGS
  market. The large market share of this segment is
  attributed to its low sequencing costs compared
  to other sequencing technologies, increased
  sensitivity in variant calling, and advancements
  in targeted genome sequencing technologies.
  Advances in targeted genome sequencing have
  enhanced the diagnosis of monogenic intestinal
  and pediatric disorders. Beyond disease
  diagnosis, this technology facilitates the
  exploration of gene-drug associations, enabling
  researchers to design gene-specific drugs with
  high specificity.
• Among the technologies, in 2025, the sequencing
  by synthesis segment is expected to account for
  the largest share of the Latin America NGS
  market. The large market share of this segment is
  attributed to the advantages offered by
  sequencing by synthesis over other technologies.
  These advantages include the elimination of
  homopolymer errors, cost-effectiveness for
  various throughput or scale requirements, robust
  performance and data quality, unbiased coverage
  across the genome, and high-quality alignment
  achieved through paired-end sequencing.
• Among the applications, in 2025, the research
  applications segment is expected to account for
  the larger share of the Latin America NGS market.
  The large market share of this segment is
  attributed to the increasing prevalence of
  genetic disorders, a rise in the adoption of
  sequencing-based tests in laboratories, the
  growing demand for gene-based medicines,
  increased investments in drug research and
  development activities, and increasing research
  programs for personalized medicine.
• Among the end users, in 2025, the pharmaceutical
  biotechnology companies segment is expected to
  account for the largest share of the Latin
  America NGS market. The large market share of
  this segment is attributed to the increasing RD
  spending by pharmaceutical and biotechnology
  companies and the rising incidence of chronic
  diseases. For instance, according to GLOBOCAN, in
  2020, 1.5 million people were diagnosed with
  cancer in Latin America. This number is projected
  to reach 1.9 million by 2032. NGS is often
  utilized to identify genomic mutations and
  variants in cancer research. NGS allows
  scientists and medical professionals to examine a
  vast amount of DNA and RNA simultaneously, aiding
  in the detection of abnormalities that might be
  connected to the disease.
• Geographic Review
• This research report provides a comprehensive
  analysis of the market in Brazil, Mexico,
  Argentina, Chile, and the Rest of Latin America.
  In 2025, Brazil is expected to account for the
  largest share of the Latin America NGS market.
  Brazil's significant market share can be
  attributed to the increasing adoption of advanced
  technologies for research purposes, the expanding
  applications of NGS in drug discovery, growing
  research and development spending by
  pharmaceutical and biotechnology companies, and
  the rising incidence of chronic diseases. These
  factors collectively drive the adoption of NGS
  technologies among pharmaceutical and
  biotechnology companies in Brazil.
• Download Sample Report Here _at_ https//www.meticulo
  usresearch.com/download-sample- report/cp_id5780
• Key questions answered in the report
• Which are the high-growth market segments in
  terms of the offering, sequencing type,
  technology, application, end user, and country?
• What was the historical market size for NGS in
  Latin America?

Meticulous Research sales_at_meticulousresearch.co
m
4
Global Latin America NGS Market 2025-2032

• What are the market forecasts and estimates for
  the period 20252032?
• What are the major drivers, restraints,
  challenges, opportunities, and trends in the
  Latin America NGS market?
• Who are the major players in the Latin America
  NGS market?
• What is the competitive landscape like, and who
  are the market leaders in the Latin America NGS
  market?
• What are the recent developments in the Latin
  America NGS market?
• What are the different strategies adopted by the
  major players in the Latin America NGS market?
• What are the geographical trends and high-growth
  countries?
• Contact Us
• Meticulous Research
• Email- sales_at_meticulousresearch.com Contact
  Sales- 1-646-781-8004
• Connect with us on LinkedIn- https//www.linkedin.
  com/company/meticulous-research

Meticulous Research sales_at_meticulousresearch.co
m